TORONTO, Aug 2, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (US:TGODF) is pleased to announce that it has successfully renewed its Health Canada licences for the Company's Ancaster, Ontario facility until August 2022.  As per the Cannabis Regulations, these

LOS ANGELES, Aug. 2, 2019 /PRNewswire/ -- Barco® Uniforms (Barco), a recognized leader of design innovation in the premium Healthcare apparel industry, celeb

ST. LOUIS, Aug. 2, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that its subsidiary Centurion, contracted in Georgia as MHM Correctional Services, LLC, was re-awarded a contract to continue the provision of mental and dental health services to the Georgia Department of Correction's (GDC) state prison facilitie

CHICAGO, Aug. 2, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for the fiscal third quarter ended June 30, 2019, and provided its fiscal fourth quarter and updated full-year 2019 financial outlook.

CHICAGO, August 2, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that it has entered into a definitive agreement to acquire Breathe Technologies, Inc., developer and manufacturer of a patented wearable, non-invasive ventilation technology that supports improved patient mobility, for a cash consideration of $130 million.

STAINES-UPON-THAMES, United Kingdom, Aug. 2, 2019 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a global biopharmaceutical company, will present on

DUBLIN, Aug. 2, 2019 /PRNewswire/ -- Endo International plc ("Endo") (NASDAQ: ENDP) today applauded the U.S. District Court for the District of Columbia's decision supporting the Food and Drug Administration's (FDA) determination that vasopressin cannot be used for compounding by outsourcing facilities.  The Court specifically c

MADISON, Wis., Aug. 2, 2019 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will be presenting at the following investor conference and invited investors to participate by webcast.Canaccord Genuity Annual Growth Conference, BostonFireside Chat on

STOCKHOLM, Aug. 2, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, today announced that the clinical phase I trial with drug candidate T20K successfully achieved its purpose of confirming T20K's safety and tolerability in humans. There were no reports of serious adverse events in this infusion study. T20K, which is under development for t

TUCSON, Ariz., Aug. 2, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced the release and CE marking of its latest Accelerate PhenoTest™ BC kit, declaring conformity to the European Directive 98/79/EC on in vitro diagnostic medical devices.